Plasma homocysteine levels, methylene tetrahydrofolate reductase polymorphisms, and the risk of thromboembolism in children

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 5, 2011, Pages 330-333

  Nahar, Akash ^a   Sabo, Cynthia ^a   Chitlur, Meera ^a   Ravindranath, Yaddanapudi ^a   Lusher, Jeanne ^a   Rajpurkar, Madhvi ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b Division of Hematology and Oncology   (United States)

Author keywords

Hyperhomocystenemia; methylene tetrahydrofolate reductase polymorphisms; pediatric thrombosis; thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE;

ADULT; AGE SPECIFIC CARE; AMINO ACID BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; THROMBOEMBOLISM; VITAMIN SUPPLEMENTATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOCYSTEINE; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; PREVALENCE; REFERENCE VALUES; RISK FACTORS; THROMBOEMBOLISM; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 79959841027     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318219324f     Document Type: Article

References (20)

1. Raffini L, Huang YS, Witmer C, et al. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics. 2009;124:1001-1008.
2. Ray JG. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med. 1998;158:2101-2106. (Pubitemid 28482092)
3. Kosch A, Koch HG, Heinecke A, et al. Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children. Thromb Haemost. 2004;91:308-314. (Pubitemid 38240177)
4. Ganji V, Kafai MR. Population references for plasma total homocysteine concentrations for U.S. children and adolescents in the post-folic acid fortification era. J Nutr. 2005;135: 2253-2256. (Pubitemid 41298396)
5. Vilaseca MA, Moyano D, Ferrer I, et al. Total homocysteine in pediatric patients. Clin Chem. 1997;43:690-692. (Pubitemid 27155058)
6. Friedman AN, Bostom AG, Selhub J, et al. The kidney and homocysteine metabolism. J Am Soc Nephrol. 2001;12: 2181-2189. (Pubitemid 32880357)
7. Kluijtmans LA, Boers GH, Verbruggen B, et al. Homozygous cystathionine beta-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis. Blood. 1998;91:2015-2018. (Pubitemid 28185503)
8. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
9. Koch HG, Nabel P, Junker R, et al. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis. Eur J Pediatr. 1999;158 (Suppl. 3):S113-S116. (Pubitemid 30014015)
10. Naess IA, Christiansen SC, Romundstad PR, et al. Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population: Results from the HUNT 2 study. Br J Haematol. 2008;141: 529-535. (Pubitemid 351550558)
11. Goyette P, Frosst P, Rosenblatt DS, et al. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/ phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet. 1995;56:1052-1059.
12. Van der Put NM, Gabreels F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet. 1998;62:1044-51. (Pubitemid 28199004)
13. Weisberg I, Tran P, Christensen B, et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64:169-172. (Pubitemid 28453294)
14. Kosch A, Junker R, Kurnik K, et al. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: A family study. Thromb Res. 2000;99:531-537. (Pubitemid 30642732)
15. Falcon CR, Cattaneo M, Panzeri D, et al. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler Thromb. 1994;14:1080-1083.
16. Balasa VV, Gruppo RA, Glueck CJ, et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost. 1999;81:739-744. (Pubitemid 29216560)
17. Chuang CZ, Boyles A, Legardeur B, et al. Effects of riboflavin and folic acid supplementation on plasma homocysteine levels in healthy subjects. Am J Med Sci. 2006;331:65-71
18. Bezemer ID, Doggen CJ, Vos HL, et al. No association between the common MTHFR 677C-T polymorphism and venous thrombosis: Results from the MEGA study. Arch Intern Med. 2007;167:497-501. (Pubitemid 46425663)
19. Ray JG, Shmorgun D, Chan WS. Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: Meta-analysis of 31 studies. Pathophysiol Haemost Thromb. 2002;32:51-58. (Pubitemid 37490507)
20. Domagala TB, Adamek L, Nizankowska E, et al. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease. Blood Coagul Fibrinolysis. 2002;13:423-431. (Pubitemid 35001859)